世界の消費者直販（DTC）遺伝子検査市場 – 業界動向と2030年までの予測

Get Exclusive Sample PDF of this Report Here

消費者直販（DTC）遺伝子検査市場の分析と規模

消費者直結型（DTC）検査はダイレクトアクセス検査とも呼ばれ、顧客が必ずしも医療提供者と協力することなく、検査室から直接検査を注文することができます。予測期間中に消費者直結型（DTC）遺伝子検査市場の成長を後押しすると予想される主な要因は、国民の警戒度の高まりです。さらに、発展途上国における所得水準の上昇も、消費者直結型（DTC）遺伝子検査市場の成長をさらに促進すると予想されます。

Data Bridge Market Researchは、消費者向け直接販売（DTC）遺伝子検査市場は2022年に15億5,051万米ドルと評価され、さらに2030年までに38億8,035万米ドルに達すると推定され、2023年から2030年の予測期間中に12.15％のCAGRで成長すると予測しています。Data Bridge Market Researchチームがまとめた市場レポートには、専門家による詳細な分析、患者の疫学、パイプライン分析、価格設定分析、および規制の枠組みが含まれています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Researchがまとめた市場レポートには、専門家による詳細な分析、患者の疫学、パイプライン分析、価格設定分析、および規制の枠組みも含まれています。

消費者向け（DTC）遺伝子検査市場の範囲とセグメンテーション

Get Exclusive Sample PDF of this Report Here

市場の定義

世界的な消費者直販（DTC）遺伝子検査市場とは、医療専門家や仲介業者を介さずに、遺伝子検査サービスや製品が消費者に直接販売される市場を指します。DTC 遺伝子検査により、個人は自分の遺伝子情報にアクセスし、祖先の追跡、健康リスク評価、個別化医療など、さまざまな目的で遺伝子情報を分析できます。この市場には、遺伝子検査キット、オンライン検査注文および結果解釈プラットフォーム、および関連サービスを提供する企業が含まれます。

消費者直販（DTC）遺伝子検査市場の動向

ドライバー

• 消費者の意識向上

Growing public awareness of the benefits of genetic testing, including ancestry, disease risk assessment, and personalized healthcare insights, has increased the demand for DTC genetic testing. Consumers are becoming more proactive about their health and want convenient and accessible ways to obtain genetic information.

• Rising Technological Advancements

Advances in gene sequencing technology and bioinformatics have greatly reduced the cost and time required for genetic testing. Technological advancements have led to a significant reduction in the cost of genetic testing. The development of high-throughput sequencing technologies, such as next-generation sequencing (NGS), has enabled the analysis of multiple genes or even entire genomes at a fraction of the cost compared to traditional methods.

• Growing Personalized Healthcare and Wellness Trends

The rise in focus on personalized healthcare and wellness, the demand for DTC genetic testing is increasing. Consumers are increasingly interested in understanding their genetic makeup to make informed decisions about their lifestyle, disease prevention, and treatment options. DTC genetic testing provides individuals with valuable insight into their unique genetic profile, enabling a personalized health approach.

Opportunity

• Rapid Expansion of Test Offerings

DTC genetic testing companies have an opportunity to diversify their testing portfolio and expand beyond parenthood and basic health-related testing. Companies are offering a wider range of genetic tests, including pharmacogenomics, nutrigenomics and carrier screening. Companies can target a wider audience and provide more comprehensive genetic insights. This will act as an opportunity for market growth.

• Increasing Partnerships with Healthcare Providers

Continued collaboration between DTC genetic testing companies and healthcare providers creates an opportunity for a more integrated and holistic approach to genetic testing. Partnering with medical institutions, DTC companies can leverage their expertise and build trust to ensure responsible use and interpretation of genetic data.

Restraints

• Lack of Data Privacy and Ethical Concerns

The DTC genetic testing market faces challenges related to data protection and the responsible use of genetic information. Genetic testing involves the collection and analysis of personal genomic data, which raises ethical and privacy concerns. Consumers may have reservations about sharing their genetic information with companies due to potential risks of unauthorized access, data breaches, or misuse of information. These concerns can limit market growth as individuals prioritize the security and privacy of their genetic data.

Challenges

• Strict Regulatory Landscape

The DTC genetic testing market operates in a complex regulatory environment. Different countries have different regulations and guidelines regarding genetic testing, data protection and the involvement of health professionals. Adapting to changing regulatory requirements and maintaining compliance can be a significant challenge for companies operating in this market.

This direct-to-consumer (DTC) genetic testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the direct-to-consumer (DTC) genetic testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

• In March 2021, 23andMe announced its plans to go public through a merger with a special purpose acquisition company (SPAC) called VG Acquisition Corp. The merger aimed to accelerate the company's growth and expand its consumer health offerings
• In February 2021, MyHeritage, a leading genealogy and genetic testing company, introduced a new product called MyHeritage Health. It combined genetic testing with family history research to provide users with a comprehensive understanding of their health risks and genetic heritage.

Global Direct-to-Consumer (DTC) Genetic Testing Market Scope

The global Direct-to-Consumer (DTC) Genetic Testing Market is segmented into seven notable segments based on service, test type, technology, product type, business model, end user, and sales channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Service

• Diagnostic screening
• Prenatal
• New-born screening
• Pre-implantation diagnosis
• Relationship testing

Test Type

• Carrier testing
• Predictive testing
• Ancestry and relationship testing
• Nutrigenomics testing and others

Technology

• Targeted analysis
• Single nucleotide polymorphism (SNP) chips
• Whole genome sequencing (WGS)

Product Type

• Ancestry
• Health and wellness
• Entertainment

Business Model

• Genome data bank material model
• Individual health planning model
• Comprehensive genome tests model
• Medical precision tests model
• Restricted trait tests model

End User

• Laboratories
• Blood banks
• Nursing homes
• Hospitals
• Imaging centers
• Home care
• Cosmetics
• Others

Sales Channel

• Online sales
• OTC sales
• Doctor's office

Global Direct-to-Consumer (DTC) Genetic Testing Market Regional Analysis/Insights

The global direct-to-consumer (DTC) genetic testing market is analyzed, and market size insights and trends are provided based on service, test type, technology, product type, business model, end user and sales channel.

The countries covered in this global direct-to-consumer (DTC) genetic testing market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the direct-to-consumer (DTC) genetic testing market due to the shift in the outlook of consumers toward genetic testing. Furthermore, the rise in expenditure will further boost the growth of the direct-to-consumer (DTC) genetic testing market in the region during the forecast period.

 Asia-Pacific is projected to observe a significant amount of growth in the direct-to-consumer (DTC) genetic testing market due to the rise in health care awareness. Moreover, the increase in disposable income is further anticipated to propel the growth of the direct-to-consumer (DTC) genetic testing market in the region in the coming years.

The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands and the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The direct-to-consumer (DTC) genetic testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for the direct-to-consumer (DTC) genetic testing market, impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the direct-to-consumer (DTC) genetic testing market. The data is available for the historic period 2015-2020.

Competitive Landscape and Direct-to-consumer (DTC) Genetic Testing Market Share Analysis

消費者直販（DTC）遺伝子検査市場の競争状況は、競合他社の詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、生産能力、会社の長所と短所、製品の発売、製品の幅と広さ、アプリケーションの優位性などがあります。提供されている上記のデータ ポイントは、消費者直販（DTC）遺伝子検査市場に関連する会社の焦点にのみ関連しています。

世界的な消費者直販（DTC）遺伝子検査市場で活動している主要企業は次のとおりです。

• EasyDNA（米国）
• 祖先（米国）
• 23andMe, Inc.（米国）
• カラーヘルス社（米国）
• ジェネシスヘルスケア（米国）
• フルゲノムコーポレーション（米国）
• Helix OpCo LLC (米国)
• リビングDNA株式会社（英国）
• Mapmygenome（インド）
• ゲノムウェブ（米国）
• ジーン・バイ・ジーン株式会社（米国）
• MyHeritage Ltd. (イスラエル)
• 10x Genomics（米国）
• ダンテ・ラボ（米国）
• 24Genetics（スペイン）
• ラボラトリー・コーポレーション・オブ・アメリカ・ホールディングス（米国）
• ミリアド・ジェネティクス社（米国）
• クエスト・ダイアグノスティクス・インコーポレーテッド（米国）
• Uniogen Oy（トルコ）

SKU-47726